The CHIPS Act and China’s Response Review: What Foreign Chip Companies Need to Know

The U.S. CHIPS and Science Act, signed in August 2022, commits $52.7 billion in semiconductor manufacturing subsidies and an additional $24 billion in tax credits to reshore advanced chip production. China has responded with a coordinated counter-strategy, including its own state-backed fund of 344 billion RMB ($47.5 billion), plus tightened export controls and a push for domestic self-sufficiency. For foreign semiconductor firms operating in or selling to China, this policy collision creates a fundamentally new risk and opportunity landscape that demands immediate strategic recalibration.

The CHIPS Act: A $52.7 Billion Gamble on Domestic Production

The CHIPS Act is the most significant U.S. industrial policy intervention in decades. It allocates $39 billion in direct manufacturing subsidies, $11 billion for R&D and workforce development, and $24 billion in a 25% investment tax credit for semiconductor fabrication facilities. The explicit goal: onshore leading-edge logic, memory, and analog chip production to reduce dependence on Asia. Foreign companies including TSMC, Samsung, and Intel have moved quickly, with TSMC alone committing $40 billion to two Arizona fabs.

The Act imposes a “guardrail” clause: recipients cannot materially expand semiconductor manufacturing capacity in “foreign countries of concern,” which includes China. They are also restricted from engaging in joint research with Chinese entities involving sensitive technologies. These restrictions are not symbolic — they create a hard fork in corporate strategy. A company that accepts U.S. subsidies cannot simultaneously invest in advanced fabs in China.

Key CHIPS Act Allocations vs. China’s Counter-Response

The data reveals a core asymmetry: the U.S. targets bleeding-edge technology while China focuses on the mature, high-volume nodes that represent 70% of global semiconductor demand by revenue. For foreign companies, the implication is stark — you can have access to U.S. subsidies and advanced nodes, or access to the Chinese market, but rarely both.

China’s Three-Pronged Response Strategy

China’s counter-move is not a single policy but a coordinated three-layer strategy: state-backed capital, export controls, and regulatory restructuring. The largest single instrument is the 国家集成电路产业投资基金 Phase III (Big Fund, guójiā jíchéng diànlù chǎnyè tóuzī jījīn), raising 344 billion RMB ($47.5 billion) in May 2024. Unlike Phase I and II, Phase III explicitly targets domestic equipment and materials companies, closing the bottleneck that created the “domestic substitution” (国产替代, guóchǎn tìdài) gap.

On the export control front, starting August 2023, China imposed export licenses on gallium, germanium, and graphite — critical materials where it controls 80–94% of global supply. In late 2024, it added antimony and superhard materials. These controls directly impact foreign fabs producing power chips, RF components, and EV semiconductors globally. The immediate effect: component cost increases of 12–18% for affected devices, according to industry procurement data.

The third layer is regulatory. China’s Ministry of Industry and Information Technology (MIIT) now mandates that these “new infrastructure” projects prioritize “safe and controllable” domestic chips for government procurement and state-owned enterprise tenders. Foreign chipmakers selling into China’s 5G base stations, data centers, and EV infrastructure are increasingly locked out unless they can demonstrate a “domestication pathway” — typically through a 中外合资企业 (joint venture, zhōngwài hézī qǐyè) with a Chinese partner.

How Foreign Chip Companies Are Actually Navigating the Crossfire

The practical outcome is a bifurcation of strategy among foreign semiconductor firms. Three distinct camps have emerged: the “U.S.-tied Pact” companies that accept CHIPS Act subsidies and wind down China exposure; the “China-market Maximizers” that avoid U.S. subsidies and double down on Chinese localization; and the “Dual-Path Hedgers” that keep China presence via mature-node JVs while taking U.S. subsidies for leading-edge fabs elsewhere.

The Dual-Path Hedgers are the most interesting. For example, one major European chipmaker runs a 28nm-plus fab in China through a WFOE while separately applying for CHIPS Act support for its advanced packaging facility in Arizona. The cost of this dual compliance is high: separate legal entities, full data segregation, no personnel overlap between the two operations, and a dedicated China compliance officer team costing $2–4 million annually.

Foreign executives should understand that China’s response moves faster than the CHIPS Act. The U.S. subsidy disbursement process has been slow — as of October 2024, only 30% of the $39 billion in manufacturing funds had been awarded. Meanwhile, China’s Big Fund Phase III began deploying capital within 90 days of launch. Speed matters: a foreign equipment supplier that delays China localization risks being locked out of bidding for domestic foundry capacity expansions that are already under construction.

Decision Framework for Foreign Semiconductor Firms

Based on the actual outcomes observed over the past 18 months, here is a practical decision framework for foreign chip companies:

If your core IP is advanced nodes (sub-7nm logic, leading-edge memory, advanced packaging), choose the CHIPS Act path. The guardrails prevent meaningful China engagement anyway, and the subsidy offsets 15–20% of your fab capital expenditure. Focus on building your China team for selling into the aftermarket, not for manufacturing.

If your strength is mature nodes (28nm and above), analog power, sensors, or wafer fabs, choose the China localization path. Avoid U.S. federal subsidies entirely. Structure a joint venture with a Chinese partner (provincial SOE preferred) to qualify for domestic substitution incentives. The China market for mature nodes is worth $62 billion annually and is growing at 8% CAGR — far too large to cede.

If you are an equipment or materials supplier, choose the dual-hub model. Maintain a separate legal entity in China to supply domestic fabs, and a non-China entity for customers in the U.S. and EU. The cost is manageable ($1–3 million setup per hub), and the revenue opportunity from China’s fabs under construction (20+ new 12-inch facilities by 2026) is substantial.

Three Pitfalls to Avoid

NEXT STEPS: Three Recommendations for Foreign Chip Executives

1. Audit your “CHIPS Act vs. China” exposure. Before any subsidy application or new Chinese market investment, map every entity in your supply chain for geographic concentration, technology node classification, and revenue exposure. Use our China Entity Audit Checklist for Semiconductor Firms to identify conflicts before they become compliance failures.

2. Structure your China legal entity for maximum flexibility. The optimal structure today combines a 外商独资企业 (WFOE, wàishāng dúzī qǐyè) for sales and service, with a joint venture for manufacturing or R&D. This allows you to benefit from local incentives (减税, jian shui, or tax reduction) while keeping IP in the WFOE. Read our Guide to Semiconductor WFOE vs. Joint Venture Structures for step-by-step setup instructions.

3. Begin domestic certification for mature-node products now. China’s push for 国产替代 is accelerating, not slowing. If you sell power management chips, MCUs, or analog ICs into the China market, start the 中国芯认证 process within 30 days. Our China Chip Certification Timeline and Cost Guide breaks down the 9-month process and estimated RMB 500,000–1.2 million cost per product family.

— China Gateway 360 —
Remote China market entry support, built around execution.